Across
- 2. A class of antihistamines that crosses the blood-brain barrier causing sedation by blocking histamine receptors (think diphenhydramine).
- 3. Short-term or temporary bouts of insomnia often managed with self-care for up to 7–10 days.
- 4. Dreaming stage of sleep
- 6. Side effects often associated with first-generation antihistamines including dry mouth/ blurred vision/ urinary retention and constipation.
- 8. mechanism by which caffeine increases cAMP levels that contribute to its stimulant effects and prevention of apnea.
- 11. set of educational interventions and behavioral practices (like maintaining a regular sleep schedule) designed to promote better sleep.
- 12. first-line non-pharmacologic intervention for insomnia that addresses dysfunctional behaviors and beliefs contributing to sleep issues.
- 13. Insomnia that are idiopathic or psychological in nature rather than caused by another medical condition.
Down
- 1. A condition where a patient reports severe insomnia symptoms that do not align with objective sleep measurements.
- 5. ratio of total sleep time to the total time spent in bed if less than 85% it is a clinical indicator of insomnia.
- 7. Sleep difficulty occurring at least three times weekly for more than three months (insomnia)
- 9. first-generation antihistamine used in some sleep aids like Unisom/ ZzzQuil/Ultra) but not the FDA's preferred agent due to limited data.
- 10. Insomnia caused by another disorder/ condition/or medication like (GERD/asthma/or antidepressants).